Eosinophilia - Revision history

Elcatracho: /* Management */

2022-01-12T17:04:22Z

Management

← Older revision		Revision as of 17:04, 12 January 2022
Line 22:		Line 22:

	==Management==		==Management==
			*Directed at underlying cause

	==Disposition==		==Disposition==

Elcatracho: /* Evaluation */

2021-03-08T20:02:28Z

Evaluation

← Older revision		Revision as of 20:02, 8 March 2021
Line 19:		Line 19:

	==Evaluation==		==Evaluation==
			*CBC with differential

	==Management==		==Management==

Elcatracho: /* Differential Diagnosis */

2021-03-08T20:02:00Z

Differential Diagnosis

← Older revision		Revision as of 20:02, 8 March 2021
Line 10:		Line 10:
	*[[DRESS syndrome]], drug-induced		*[[DRESS syndrome]], drug-induced
	*[[Parasitic infection]]		*[[Parasitic infection]]
	*[[Coccidioidomycosis]] and other fungal infections		*[[Coccidioidomycosis]] and other [[fungal infections]]
	*Malignancy (e.g. [[lymphoma]], eosinophilic [[leukemia]])		*Malignancy (e.g. [[lymphoma]], eosinophilic [[leukemia]])
	*Skin disorders (e.g. [[bullous pemphigoid]], dermatitis herpetiformis)		*Skin disorders (e.g. [[bullous pemphigoid]], dermatitis herpetiformis)

ClaireLewis: /* Differential Diagnosis */

2019-10-01T00:25:34Z

Differential Diagnosis

← Older revision		Revision as of 00:25, 1 October 2019
Line 6:		Line 6:

	==Differential Diagnosis==		==Differential Diagnosis==
	*[[Allergic reaction]] or other ~~hypsersensitivity~~/atopic state		*[[Allergic reaction]] or other hypersensitivity/atopic state
	**[[Urticaria]], [[atopic dermatitis]], [[asthma]], drug reaction/hypersensitivity		**[[Urticaria]], [[atopic dermatitis]], [[asthma]], drug reaction/hypersensitivity
	*[[DRESS syndrome]], drug-induced		*[[DRESS syndrome]], drug-induced
Line 14:		Line 14:
	*Skin disorders (e.g. [[bullous pemphigoid]], dermatitis herpetiformis)		*Skin disorders (e.g. [[bullous pemphigoid]], dermatitis herpetiformis)
	*[[Adrenal insufficiency]]		*[[Adrenal insufficiency]]
	*Connective tissue disease (e.g. [[Churg-Strauss syndrome]])		*[[Connective tissue disease]] (e.g. [[Churg-Strauss syndrome]])
	*Interstitial nephritis		*Interstitial nephritis
	*[[Arsenic]], [[gold toxicity]]		*[[Arsenic]], [[gold toxicity]]

ClaireLewis: /* Differential Diagnosis */

2019-08-26T18:37:25Z

Differential Diagnosis

← Older revision		Revision as of 18:37, 26 August 2019
Line 8:		Line 8:
	*[[Allergic reaction]] or other hypsersensitivity/atopic state		*[[Allergic reaction]] or other hypsersensitivity/atopic state
	**[[Urticaria]], [[atopic dermatitis]], [[asthma]], drug reaction/hypersensitivity		**[[Urticaria]], [[atopic dermatitis]], [[asthma]], drug reaction/hypersensitivity
	*[[DRESS syndrome]]		*[[DRESS syndrome]], drug-induced
	*[[Parasitic infection]]		*[[Parasitic infection]]
	*[[Coccidioidomycosis]] and other fungal infections		*[[Coccidioidomycosis]] and other fungal infections
Line 16:		Line 16:
	*Connective tissue disease (e.g. [[Churg-Strauss syndrome]])		*Connective tissue disease (e.g. [[Churg-Strauss syndrome]])
	*Interstitial nephritis		*Interstitial nephritis
	*[[Arsenic]]		*[[Arsenic]], [[gold toxicity]]

	==Evaluation==		==Evaluation==

ClaireLewis: /* Background */

2016-10-04T23:03:03Z

Background

← Older revision		Revision as of 23:03, 4 October 2016
Line 1:		Line 1:
	==Background==		==Background==
	*Defined usually as peripheral eosinophil count >0.5 x 10<sup>9</sup>/L		*Defined usually as peripheral eosinophil count >0.5 x 10<sup>9</sup>/L
	*Eosinophils ~~usually account for~~ <7% of total WBC count		*Eosinophils normally comprise <7% of total WBC count

	==Clinical Features==		==Clinical Features==

ClaireLewis: Created page with "==Background== Defined usually as peripheral eosinophil count >0.5 x 10⁹/L Eosinophils usually account for <7% of total WBC count ==Clinical Features== ==Diff..."

2016-10-04T23:02:28Z

Created page with "==Background== *Defined usually as peripheral eosinophil count >0.5 x 10<sup>9</sup>/L *Eosinophils usually account for <7% of total WBC count ==Clinical Features== ==Diff..."

New page

==Background==
*Defined usually as peripheral eosinophil count >0.5 x 10<sup>9</sup>/L
*Eosinophils usually account for <7% of total WBC count

==Clinical Features==

==Differential Diagnosis==
*[[Allergic reaction]] or other hypsersensitivity/atopic state
**[[Urticaria]], [[atopic dermatitis]], [[asthma]], drug reaction/hypersensitivity
*[[DRESS syndrome]]
*[[Parasitic infection]]
*[[Coccidioidomycosis]] and other fungal infections
*Malignancy (e.g. [[lymphoma]], eosinophilic [[leukemia]])
*Skin disorders (e.g. [[bullous pemphigoid]], dermatitis herpetiformis)
*[[Adrenal insufficiency]]
*Connective tissue disease (e.g. [[Churg-Strauss syndrome]])
*Interstitial nephritis
*[[Arsenic]]

==Evaluation==

==Management==

==Disposition==

==See Also==
*[[Leukocytosis]]

==External Links==

==References==
<references/>

[[Category:Heme/Onc]]

Eosinophilia - Revision history

Elcatracho: /* Management */

Elcatracho: /* Evaluation */

Elcatracho: /* Differential Diagnosis */

ClaireLewis: /* Differential Diagnosis */

ClaireLewis: /* Differential Diagnosis */

ClaireLewis: /* Background */

ClaireLewis: Created page with "==Background== *Defined usually as peripheral eosinophil count >0.5 x 109/L *Eosinophils usually account for <7% of total WBC count ==Clinical Features== ==Diff..."

ClaireLewis: Created page with "==Background== Defined usually as peripheral eosinophil count >0.5 x 10⁹/L Eosinophils usually account for <7% of total WBC count ==Clinical Features== ==Diff..."